Category Archives for "drug product injuries"

Jan 25

ARB Blood Pressure Medicine Recalls Expanding

By Joe Messa

Since late last year, several pharmaceutical companies have been slowly recalling various lots of blood pressure medications containing valsartan, irbesartan, or losartan. The recalled drugs are believed to potentially contain an impurity called N-nitrosodiethylamine (NDEA). NDEA is a known animal and probable human carcinogen (Group 2A) most often found in tobacco smoke. The medications involved […]

Continue reading
Dec 06

RECALL: Infant Ibuprofen sold at Walmart, CVS, and Family Dollar

By Joe Messa

Tris Pharma, Inc., a New Jersey based pharmaceutical manufacturer, has issued a voluntary recall of infant ibuprofen that may contain higher concentrations than noted on the bottle, leading to potential risks in infants. The impacted lots of medication were sold to a distributor that supplies retailers, including CVS, Walmart, and Family Dollar. Retailers and wholesalers […]

Continue reading
Jun 12

Humira-related deaths put pharma company, AbbVie, in the spotlight

By Joe Messa

As far as pharmaceutical giants are concerned, AbbVie might not be a household name, but the company’s blockbuster drug, Humira, certainly is. Humira is an immunosuppresive approved to treat arthritis, plaque psoriasis, ankylosing spondylitis, Crohn’s disease, and ulcerative colitis. Recently, the United States Food & Drug Administration (FDA) slammed the Chicago-based pharmaceutical company for not […]

Continue reading
May 10

White Coat Marketing: More unscrupulous behavior from the pharmaceutical industry

By Joe Messa

Novo Nordisk, a Danish pharmaceutical company focused on manufacturing medicinal treatments for diabetes, obesity, Haemophilia, growth hormone therapy, and hormone replacement therapy, has been accused in a lawsuit filed on behalf of the Federal Government of engaging in a “white coat marketing scheme” to persuade doctors to prescribe three of its diabetes treatments – NovoLog, […]

Continue reading
1 2 3 8